Docosatetraenylethanolamide
Docosatetraenylethanolamide (DEA) is a cannabinoid receptor 1 (CB1) agonist. Docosatetraenylethanolamide inhibits the specific binding of cannabinoid probe to rat synaptosomal membranes with a Ki value of 34.4 nM. Docosatetraenylethanolamide can be used in the research of nervous system[1][2].
Product Specifications
Product Name Alternative
DEA
UNSPSC
12352211
Hazard Statement
H225-H350
Target
Cannabinoid Receptor; Endogenous Metabolite
Related Pathways
GPCR/G Protein; Metabolic Enzyme/Protease; Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Neurological Disease
Solubility
10 mM in DMSO
Smiles
CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(NCCO)=O
Molecular Formula
C24H41NO2
Molecular Weight
375.59
Precautions
P210-P233-P240-P241-P242-P243-P280-P303+P361+P353-P370+P378-P403+P235-P405-P501
References & Citations
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-110016/
Scientific Category
Natural Products
Clinical Information
No Development Reported
Isoform
CB1
CAS Number
[150314-35-5]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items